<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2020.10110147</article-id><article-id pub-id-type="publisher-id">OJOG-104514</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Neonatal Outcome of Induced Prematurity for Severe Preeclampsia in Four Great Kinshasa Maternities
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Olive</surname><given-names>Yalala Ambambula</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andy</surname><given-names>Muela Mbangama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Therese</surname><given-names>Biselele</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rashid</surname><given-names>Rahma Tozin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dieudonné</surname><given-names>Mushengezi Sengeyi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Pediatrics, University Clinics of Kinshasa, Kinshasa, DR Congo</addr-line></aff><aff id="aff1"><addr-line>Department of Obstetrics and Gynecology, University Clinics of Kinshasa, Kinshasa, DR Congo</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>11</month><year>2020</year></pub-date><volume>10</volume><issue>11</issue><fpage>1637</fpage><lpage>1643</lpage><history><date date-type="received"><day>25,</day>	<month>September</month>	<year>2020</year></date><date date-type="rev-recd"><day>27,</day>	<month>November</month>	<year>2020</year>	</date><date date-type="accepted"><day>30,</day>	<month>November</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Severe preeclampsia (SPE) is associated with fetal complications including intrauterine growth retardation (IUGR), prematurity and in utero fetal death. Its treatment remains child birth that often is planned before term. However, this attitude can lead to fetal complications related to prematurity. Several studies on preeclampsia have already been studied in the DRC and several aspects have already been realized, but to date, the neonatal outcome has not yet been addressed. 
  <b>Methods:</b>
   This is cross-sectional study performed in four public hospitals in Kinshasa (Democratic Republic of Congo). We included 400 cases of induced prematurity (IP) for SPE; the analysis compared pregnant women who gave birth before 34 weeks of amenorrhea (WA) and those after 34 WA. The comparison of the proportions was made by the Chi
  -
  square test and the calculation of Means by the Student’s test. The significance level was set at P &lt; 0.05. <b>Objective:</b> To determine the frequency of induced prematurity for severe preeclampsia (SPE), to identify the indications and to evaluate neonatal outcome. <b>Results:</b> The IP frequency for SPE was 46.2%. The retro placental hematoma was the most indication in pregnancies before 34 WA 24.9%, while high blood pressure 54.5% in the after 34 WA group. In utero death was more common in pregnant women who gave birth before 34 weeks 25.4%; chronic fetal distress was elevated in the after 34 WA group 19.5%. Neonatal infection was more common in the group after 34 WA 49.4%, while respiratory distress 39.6%, intra and periventricular hemorrhage 19.5% and neonatal death 39.6% were more in group before 34
   
  WA. <b>Conclusion:</b> Prematurity induced for SPE is related to a poor neonatal
   prognosis.
 
</p></abstract><kwd-group><kwd>Preeclampsia</kwd><kwd> Induced Prematurity</kwd><kwd> Neonatal Outcome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Severe preeclampsia (SPE) is associated with fetal complications including intrauterine growth retardation (IUGR), prematurity and in utero fetal death [<xref ref-type="bibr" rid="scirp.104514-ref1">1</xref>]. Its treatment remains childbirth that often is planned before term [<xref ref-type="bibr" rid="scirp.104514-ref2">2</xref>]. However, this attitude can lead to fetal complications related to prematurity [<xref ref-type="bibr" rid="scirp.104514-ref3">3</xref>].</p><p>According to WHO, preterm birth is defined as any childbirth occurring between 22 and 37 weeks of age [<xref ref-type="bibr" rid="scirp.104514-ref4">4</xref>]. In Low-income countries like the DRC, childbirth is premature when it occurs between 28 and 37 weeks of age [<xref ref-type="bibr" rid="scirp.104514-ref5">5</xref>]. Its prevalence varies between 60/1000 and 120/1000 of live births in developed countries [<xref ref-type="bibr" rid="scirp.104514-ref4">4</xref>]. In Europe, it is 8% and in the USA it represents 12% [<xref ref-type="bibr" rid="scirp.104514-ref6">6</xref>]. This last high rate is essentially represented by induced prematurity. In Africa, the situation is complicated, particularly in Low-income countries like those in sub-Saharan Africa, which alone account for 22% of premature births [<xref ref-type="bibr" rid="scirp.104514-ref3">3</xref>]. In the DRC, prematurity accounts for 15% [<xref ref-type="bibr" rid="scirp.104514-ref5">5</xref>] and University Hospital of Kinshasa is 40% [<xref ref-type="bibr" rid="scirp.104514-ref7">7</xref>].</p><p>We can classify prematurity in “extremely premature” when the delivery occurs before 28 WA; “high prematurity” when childbirth is between 28 SA and 32 WA; “moderate prematurity” when the delivery occurs between 33 WA and 36 WA.</p><p>In prematurity in general, there is a problem of immaturity of all organs anatomically and functionally. Nevertheless, what is most feared are the pulmonary problems and the appearance of motor sequel following cortical attacks. Other complications may include cerebral hemorrhage, hypothermia, hypoglycemia and hypocalcaemia [<xref ref-type="bibr" rid="scirp.104514-ref2">2</xref>]. Prematurity in the context of SPE is generally induced (iatrogenic decided by the medical team when the continuation of the pregnancy is threatening for the mother and/or the fetus) contrary to the spontaneous prematurity (which intervenes in the context of spontaneous work delivery) [<xref ref-type="bibr" rid="scirp.104514-ref6">6</xref>].</p><p>Several studies on preeclampsia have already been studied in the DRC and several aspects have already been realized, but to date the neonatal outcome has not yet been addressed that is the reason why we initiate this study which aims to determine frequency of induced prematurity for SPE; to identify indications of is induced prematurity and to evaluate its neonatal prognosis.</p></sec><sec id="s2"><title>2. Methods</title><p>Our study is cross-sectional, conducted in the severe preeclampsia who gave birth in the context of IP and their newborns in four public maternities in the city of Kinshasa namely: The University Hospitals of Kinshasa, the Ngaliema Clinic, the Saint Joseph Hospital and the Provincial General Hospital of Reference of Kinshasa. The study period was from January 2013 to December 2017. The women were then divided into 2 groups: those who gave birth before 34 WA and those who gave birth after 4 WA.</p><sec id="s2_1"><title>2.1. Inclusion Criteria</title><p>We included in the study:</p><p>&#173; Pregnant women who had preeclampsia during the study period;</p><p>&#173; Preterm infants born from these women from the 28<sup>th</sup> week to the 37<sup>th</sup> in a single fetal pregnancy.</p></sec><sec id="s2_2"><title>2.2. Exclusion Criteria</title><p>&#173; Pregnancies of less than 28 weeks and more than 37 completed weeks;</p><p>&#173; All situations that may lead to prematurity: multiple pregnancies, urinary tract infection, malaria, Premature rupture of membranes (PRM), etc.</p><p>Statistical analyzes: The Student’s T test was used for the comparison of the means while the Chi-square was used for the comparison of the proportions. The significance level was set at P ≤ 0.05.</p></sec><sec id="s2_3"><title>2.3. Statistical Calculations</title><p>Data were entered using Microsoft Excel 2007 software and exported to SPSS 21.0 for analysis. For normally distributed parametric data, comparisons of averages were made using t-test and comparisons of proportions with chi-square test.</p><p>Pearson’s correlation test between biologic markers was used to seek potential associations with oxidative stress. Testing was stated significant at P ≤ 0.05.</p><p>This study has been designed and financed by our own funds.</p></sec><sec id="s2_4"><title>2.4. Ethical Considerations</title><p>This project was prepared according to the Declaration of Helsinki and was agreed by Ethics Committee of Department of Obstetrics and Gynecology, University clinics of Kinshasa.</p></sec></sec><sec id="s3"><title>3. Results</title><p>During the period from January 2013 to December 2017, 23,945 deliveries were recorded, including 2192 cases of preeclampsia (9.1%) including 1503 cases of severe preeclampsia; and 1012 cases of preterm delivery (4.2%). We noted 400 cases of induced prematurity for severe preeclampsia, which represents a frequency of 1.7% of all deliveries, 18.3% of cases of preeclampsia and 39.5% of cases of preterm delivery.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows that the mean age of the study group was 29.5 &#177; 6.8 years. The majority were married and primipara. The mean pregnancy age at diagnosis of PE was 32 &#177; 3.01 weeks. The diagnosis of severe preeclampsia was early, at 30.8 &#177; 2.7 WA in the group of pregnant women who gave birth before 34 WA compared to the group who gave birth after 34 WA with a highly significant difference (P &lt; 0.001). Furthermore, no statistically significant difference was noted when comparing the other features.</p><p>The most frequent indications of induced prematurity were persistence of high blood pressure figures with 49.3% followed by eclampsia with 18.8% and retro placental hematoma (RPH) with 17.8%.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Indications of Induced Prematurity (IP)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Indication of IP</th><th align="center" valign="middle"  colspan="2"  >Premature ≥ 34 WA</th><th align="center" valign="middle"  colspan="2"  >Premature &lt; 34 WA</th><th align="center" valign="middle"  colspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >SPE (HBP↗)</td><td align="center" valign="middle" >126</td><td align="center" valign="middle" >54.5</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >197</td><td align="center" valign="middle" >49.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Eclampsia</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >18.6</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >18.9</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >18.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Retroplanetal hematoma</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >12.6</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >24.9</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >17.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Eclamptic Prodrome</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >8.9</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >Chronic fetal distress</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >4.8</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.7</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >4.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hellp Syndrome</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >231</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >169</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >400</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>RPH was significantly more prevalent in the gestational group who gave birth before the 34th week of gestation (24.9% vs. 12.6% P &lt; 0.05), whereas persistence of high blood pressure in the pregnant group who delivered from the 34th week (54.5% vs 42%, P &lt; 0.05) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Fetal complications of severe preeclampsia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Fetal complications</th><th align="center" valign="middle"  colspan="2"  >Premature ≥ 34 WA</th><th align="center" valign="middle"  colspan="2"  >Premature &lt; 34 WA</th><th align="center" valign="middle"  colspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Oligohydramnios</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >27.7</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >21.9</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >25.3</td><td align="center" valign="middle" >0.114</td></tr><tr><td align="center" valign="middle" >DIU</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >12.6</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >25.4</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >&lt;0.002</td></tr><tr><td align="center" valign="middle" >CFD</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >19.5</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >&lt;0.05</td></tr></tbody></table></table-wrap><p>Oligohydramnios (25.3%), Death in utero (DIU) (18%) and chronic fetal distress (16%) are the fetal most common complications of the SPE. DIU was a more common complication before 34 WA (34.4% vs 12.6%, P &lt; 0.002), while CFD was more found after 34 weeks (19.5% vs 13%, P &lt; 0.05).</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows that infants born with premature labor induced had, as frequent complications, neonatal infection (40.3%), respiratory distress (34.5%), neonatal death (26.5%), neonatal hypoglycemia (21.3%) and Cerebral meningeal hemorrhage (CMH) (13.5%), comparing the group of pregnant women who gave birth prematurely from the 34th week to those who gave birth before 34 weeks, only neonatal infection was significantly more common in the first group (49.4% vs 27.8%, P &lt; 0. 001) while neonatal complications significantly more frequent in the second group were respiratory distress (39.6% vs 30.7% P &lt; 0.05), neonatal death (39.6% vs 16.9%, P &lt; 0.001) and cerebral meningeal hemorrhage 9.1% vs 19.5%, P &lt; 0.003).</p></sec><sec id="s4"><title>4. Discussion</title><p>The frequency of prematurity induced for severe preeclampsia was 46.2%. It is higher than that reported by the WHO that was 40% in 2013 [<xref ref-type="bibr" rid="scirp.104514-ref8">8</xref>]. This difference could be explained by the lack of regular monitoring of prenatal consultation in our communities. The same reasons are incriminated for the results found by Diguisto et al. [<xref ref-type="bibr" rid="scirp.104514-ref9">9</xref>] who report that 2.5% of these births occurred after a tripping or caesarean section before labor.</p><p>Our frequency is lower than that reported by Nvondo [<xref ref-type="bibr" rid="scirp.104514-ref10">10</xref>] in Cameroon which noted a rate of 65%. This difference could be explained by the fact that in our study we excluded all the other pathologies as well as all the other circumstances which can lead to prematurity (the PRM, the malaria, the urinary infection, multiple pregnancies...).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Neonatal outcome of severe preeclampsia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Neonatal Complications</th><th align="center" valign="middle"  colspan="2"  >Premature ≥ 34 WA</th><th align="center" valign="middle"  colspan="2"  >Premature &lt; 34 WA</th><th align="center" valign="middle"  colspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Neonatal Infection</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >49.4</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >27.8</td><td align="center" valign="middle" >161</td><td align="center" valign="middle" >40.3</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Respiratory Distress</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >30.7</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >39.6</td><td align="center" valign="middle" >138</td><td align="center" valign="middle" >34.5</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >Neonatal death</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >16.9</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >39.6</td><td align="center" valign="middle" >106</td><td align="center" valign="middle" >26.5</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >NN Hypoglycemia</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >22.1</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >20.1</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >21.3</td><td align="center" valign="middle" >0.365</td></tr><tr><td align="center" valign="middle" >CMH</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >19.5</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >13.5</td><td align="center" valign="middle" >&lt;0.003</td></tr><tr><td align="center" valign="middle" >NN Icterus</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.7</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.497</td></tr></tbody></table></table-wrap><p>In our series, 95.2% of the indications of onset were of maternal origin (SPE, eclampsia, RPH and eclamptic prodromes) versus 4.8% fetal origin (CFD). This result is contrary to that found by Fournier [<xref ref-type="bibr" rid="scirp.104514-ref8">8</xref>] where 51% of indications were of maternal origin against 41% of fetal origin and 8% of mixed origin. This difference could be explained by the fact that the socio-economic level is very low in our environment, the recording of the fetal heart rate is not done as expected due to lack of financial means and/or apparatus equipped with option Doppler ultrasound</p><p>In our study, premature neonates had neonatal infection, respiratory distress and neonatal death complications in 40.3%, 34.5% and 26.5%, respectively. Comparing the group of pregnant women who gave birth prematurely from 34 WA who gave birth before 34 WA, only neonatal infection was significantly more common in the first group (49.4% vs 27.8%, P &lt; 0.001) while neonatal complications significantly more frequent in the second group were respiratory distress (39.6% vs 30.7%: P &lt; 0.05), neonatal death (39% vs 16.9%: P &lt; 0.001) and CMH (19.5% vs 9.1%, P &lt; 0.001). This result is similar to that found by Hilal et al. [<xref ref-type="bibr" rid="scirp.104514-ref2">2</xref>] who noted that respiratory distress had a frequency of 38%.</p><p>Neonatal death was estimated at 26.5% in our study. This frequency is close to one found by Tchaoun et al. [<xref ref-type="bibr" rid="scirp.104514-ref11">11</xref>] which was 28%.</p></sec><sec id="s5"><title>5. Conclusions</title><p>The frequency of induced prematurity was 4.2% of births and 46.2% in cases of SPE; induced Prematurity for SPE avoids in utero death, exposes newborns to the complications of prematurity: The main indications are the persistence of high blood pressure while HRP was the most frequent indication in the group of pregnant women having given birth before 34 weeks; “the neonatal outcome was poor with 26.5% of deaths due to neonatal infection, respiratory distress and metabolic disorders (hypoglycemia); premature infants who were born from 34 WA had more neonatal infection than those before 34 WA while those born before 34 WA had more respiratory distress, neonatal death and CMH.</p><p>Neutropenia, sepsis and prolongation of the duration of ventilation could not be observed in our due to the lack of holistic management in our setting.</p><p>Our study shows that the neonatal prognosis is poorer for newborns before 34 WA, hence the advantage of prolonging the pregnancy until at least 34 WA if the maternal-fetal condition allows it.</p></sec><sec id="s6"><title>Author’s Contributions</title><p>All the authors contributed from the conception to the final writing of the article.</p></sec><sec id="s7"><title>Acknowledgements</title><p>The authors thank the Heads of Service of the four maternities concerned for the facilities granted for the data collection as well as Dr. Charles UMESUMBU SHAKU for the English translation.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Ambambula, O.Y., Mbangama, A.M., Biselele, T., Tozin, R.R. and Sengeyi, D.M. (2020) Neonatal Outcome of Induced Prematurity for Severe Preeclampsia in Four Great Kinshasa Maternities. Open Journal of Obstetrics and Gynecology, 10, 1637-1643. https://doi.org/10.4236/ojog.2020.10110147</p></sec></body><back><ref-list><title>References</title><ref id="scirp.104514-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ancel</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>National Epidemiological Study for Enhanced Knowledge of Care and Subsequent Development of Very Premature Children</article-title><source> Epipage</source><volume> 2</volume>,<fpage> 5</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.104514-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ozkan, H., Cetinkaya, M. and Koksal, N. (2012) Increased Incidence of Bronchopulmonary Dysplasia in Pretem Infants Exposed to Preeclampsia. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 25, 2681-2685.  
https://doi.org/10.3109/14767058.2012.708371</mixed-citation></ref><ref id="scirp.104514-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ravi, T., Henning, H., Wiebecke, S., Bernhard, R., Tuelay, C., Karumanchi, A., et al. (2016) Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. Journal of the American Society of Nephrology, 27, 903-913.  
https://doi.org/10.1681/ASN.2015020157</mixed-citation></ref><ref id="scirp.104514-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cetinkayo, M., et al. (2010) Neonatal Outcomes of Premature Infant Born to Preeclamptic Mothers. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 23, 425-430. https://doi.org/10.3109/14767050903184173</mixed-citation></ref><ref id="scirp.104514-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Jelin, A.C., Chengy, W., Shaffer, B.L. and Kairel, A. (2010) Early Onset PE and Neonatal Outcomes. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 23, 389-392. https://doi.org/10.3109/14767050903168416</mixed-citation></ref><ref id="scirp.104514-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bosso</surname><given-names> O. </given-names></name>,<etal>et al</etal>. (<year>2015</year>)<article-title>Tendances dans la survie f&amp;#339tale et infantile après prééclampsie</article-title><source> JAMA</source><volume> 296</volume>,<fpage> 1357</fpage>-<lpage>1362</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.104514-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shrestha, S., Paudel, S., Parajuli, P. and Khagi, B.R. (2017) Neonatal Outcome of Mothers with Pregnancy Induced Hypertension in Antenatal Ward of Kathmandu Medical College and Teaching Hospital. Birat Journal of Health Sciences, 2, 255-259. https://doi.org/10.3126/bjhs.v2i3.18937</mixed-citation></ref><ref id="scirp.104514-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fournier</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>rématurité spontanée ou induite, quelle influence sur l’avenir du nouveau-né</article-title><source> Gynecology and Obsetrics</source><volume> 34</volume>,<fpage> 1</fpage>-<lpage>2</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.104514-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Weymuller, V., Diguisto, C., Guellier, C. and Perrotin, F. (2016) Practice Indicated Preterm Birth in a Type 3 Maternity. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 45, 724-730. https://doi.org/10.1016/j.jgyn.2015.08.012</mixed-citation></ref><ref id="scirp.104514-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nvondo, N. (2016) Facteur de risque et devenir hospitalier des nouveau-nés prématurés à l’hopital Gynécologique et Pédiatrique de Yaoundé. Journal de Pédiatrie et de puériculture, 23, 67.</mixed-citation></ref><ref id="scirp.104514-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Tchaoun, B.A., Salefou, K., Hounkpure, F.M. and Chlobé, M. (2012) Prise en charge de la prééclampsie sévère dans l’hopital Universitaire de Parakou. Vol. 17, No. 2.</mixed-citation></ref></ref-list></back></article>